Shaikh Adnan Al, Alsofyani Areej, Shirah Bader, Noaim Khalid Al, Ahmed Mohamed E, Babiker Amir, Alwan Ibrahim Al
King Abdulaziz Medical City, National Guard Health Affairs, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Department of Pediatric, College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Int J Health Sci (Qassim). 2021 Jan-Feb;15(1):17-21.
Congenital hypothyroidism (CH) is a common cause of preventable severe neurocognitive impairment in children. Previously conducted studies describing the natural history of CH in Saudi Arabia were either of shorter duration or a limited number of patients. In this study, we aim to assess our experience in the clinical course and therapeutic outcome of CH in two large tertiary centers in Saudi Arabia.
This is a retrospective chart review of patients <18 years of age diagnosed with CH at King Abdulaziz Medical City in Jeddah and Riyadh, Saudi Arabia, between 2000 and 2018. Data were collected from the patients' medical records, including epidemiological, clinical, laboratory, and radiological features as well as a long-term outcome of CH. Statistical analysis was carried out using the JMP statistical software. This study was approved by the Institutional Review Board (IRB) at King Abdullah International Medical Research Center (KAIMRC).
Out of the 71 cases, 53.5% were female, and 80.3% of these cases were diagnosed in the 1 week of life. The estimated incidence of CH is 1:2470 in the two study centers. Ectopic thyroid (43%, = 25/58), dyshormonogenesis (34.5%, = 20/58), and thyroid agenesis and hypoplasia (22.4%, = 13/58). Learning difficulty was significantly associated with delayed treatment onset ( = 0.044) and lower compliance with treatment ( = 0.001).
In our study, the incidence of dyshormonogenesis in CH is higher than international rates (34.5% vs. 20%), possibly because of consanguinity. Effective neonatal screening program facilitates early diagnosis that leads to prompt management of CH and avoidance of long-term outcome of neurocognitive impairment.
先天性甲状腺功能减退症(CH)是儿童可预防的严重神经认知障碍的常见原因。先前在沙特阿拉伯进行的描述CH自然病史的研究,要么持续时间较短,要么患者数量有限。在本研究中,我们旨在评估沙特阿拉伯两个大型三级中心在CH临床病程和治疗结果方面的经验。
这是一项对2000年至2018年期间在沙特阿拉伯吉达和利雅得的阿卜杜勒阿齐兹国王医疗城诊断为CH的18岁以下患者的回顾性病历审查。从患者的病历中收集数据,包括流行病学、临床、实验室和放射学特征以及CH的长期结果。使用JMP统计软件进行统计分析。本研究获得了阿卜杜拉国王国际医学研究中心(KAIMRC)机构审查委员会(IRB)的批准。
在71例病例中,53.5%为女性,其中80.3%在出生后1周内被诊断出。两个研究中心CH的估计发病率为1:2470。异位甲状腺(43%,n = 25/58)、激素合成障碍(34.5%,n = 20/58)以及甲状腺缺如和发育不全(22.4%,n = 13/58)。学习困难与治疗开始延迟(P = 0.044)和治疗依从性较低(P = 0.001)显著相关。
在我们的研究中,CH中激素合成障碍的发病率高于国际水平(34.5%对20%),可能是由于近亲结婚。有效的新生儿筛查计划有助于早期诊断,从而促使对CH进行及时管理,并避免神经认知障碍的长期后果。